Bank of Montreal’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.7M Buy
331,904
+39,815
+14% +$8.25M 0.02% 516
2026
Q1
$65.6M Buy
292,089
+55,728
+24% +$13.9M 0.02% 471
2025
Q4
$56.9M Buy
236,361
+32,881
+16% +$8.41M 0.02% 516
2025
Q3
$55.7M Sell
203,480
-128,166
-39% -$35M 0.02% 467
2025
Q2
$85.6M Sell
331,646
-35,728
-10% -$8.52M 0.04% 300
2025
Q1
$82.2M Sell
367,374
-25,085
-6% -$5.86M 0.04% 301
2024
Q4
$89.8M Buy
392,459
+151,166
+63% +$36.4M 0.04% 310
2024
Q3
$57.7M Sell
241,293
-10,197
-4% -$2.28M 0.03% 425
2024
Q2
$47.1M Buy
251,490
+99,106
+65% +$20.1M 0.01% 490
2024
Q1
$29.9M Sell
152,384
-7,645
-5% -$1.4M 0.01% 607
2023
Q4
$27.9M Sell
160,029
-49,624
-24% -$7.62M 0.01% 669
2023
Q3
$30.8M Buy
209,653
+104,295
+99% +$18.9M 0.01% 575
2023
Q2
$24.6M Sell
105,358
-60,614
-37% -$13.5M 0.01% 662
2023
Q1
$36.4M Buy
165,972
+42,675
+35% +$9.26M 0.01% 477
2022
Q4
$25.9M Buy
123,297
+8,677
+8% +$1.91M 0.01% 610
2022
Q3
$25.5K Sell
114,620
-23,143
-17% -$5.27M 0.01% 599
2022
Q2
$29.3K Buy
137,763
+8,685
+7% +$1.85M 0.01% 609
2022
Q1
$32.2M Sell
129,078
-29,339
-19% -$7.1M 0.02% 616
2021
Q4
$41.6M Sell
158,417
-33,928
-18% -$8.8M 0.02% 490
2021
Q3
$51.1M Buy
192,345
+15,356
+9% +$4.2M 0.02% 550
2021
Q2
$43.7M Buy
176,989
+32,502
+22% +$6.83M 0.02% 564
2021
Q1
$28.5M Sell
144,487
-28,119
-16% -$5.64M 0.02% 568
2020
Q4
$38M Buy
172,606
+53,111
+44% +$10.6M 0.03% 499
2020
Q3
$20M Sell
119,495
-35,338
-23% -$6.53M 0.02% 587
2020
Q2
$30M Buy
154,833
+21,047
+16% +$3.44M 0.03% 463
2020
Q1
$20.1M Sell
133,786
-58,925
-31% -$9.39M 0.02% 498
2019
Q4
$29.9M Buy
192,711
+37,778
+24% +$5.44M 0.02% 564
2019
Q3
$20.9M Sell
154,933
-2,733
-2% -$358K 0.02% 616
2019
Q2
$19.2M Sell
157,666
-2,245
-1% -$249K 0.02% 653
2019
Q1
$16.6M Buy
159,911
+23,609
+17% +$2.44M 0.01% 669
2018
Q4
$15.5M Sell
136,302
-9,532
-7% -$1.02M 0.01% 635
2018
Q3
$16.8M Buy
145,834
+13,568
+10% +$1.49M 0.01% 711
2018
Q2
$13.7M Sell
132,266
-6,410
-5% -$649K 0.01% 762
2018
Q1
$13.7M Buy
138,676
+2,059
+2% +$195K 0.01% 743
2017
Q4
$11.6M Buy
136,617
+18,361
+16% +$1.52M 0.01% 803
2017
Q3
$9.1M Buy
118,256
+11,084
+10% +$848K 0.01% 889
2017
Q2
$8.35M Sell
107,172
-68,172
-39% -$4.88M 0.01% 922
2017
Q1
$12.6M Buy
175,344
+30,703
+21% +$2.12M 0.01% 725
2016
Q4
$8.89M Sell
144,641
-66,166
-31% -$4.05M 0.01% 847
2016
Q3
$13.7M Buy
210,807
+6,309
+3% +$420K 0.01% 683
2016
Q2
$12.9M Sell
204,498
-8,228
-4% -$485K 0.01% 699
2016
Q1
$12.3M Buy
212,726
+95,510
+81% +$5.41M 0.01% 656
2015
Q4
$6.29M Buy
117,216
+95,116
+430% +$5.36M 0.01% 913
2015
Q3
$1.13M Buy
22,100
+525
+2% +$28.3K ﹤0.01% 1527
2015
Q2
$1.22M Buy
21,575
+2,446
+13% +$154K ﹤0.01% 1583
2015
Q1
$1.37M Sell
19,129
-17,996
-48% -$1.17M ﹤0.01% 1510
2014
Q4
$2.08M Sell
37,125
-21,502
-37% -$1.12M ﹤0.01% 1395
2014
Q3
$2.89M Sell
58,627
-10,803
-16% -$550K ﹤0.01% 1311
2014
Q2
$3.51M Buy
69,430
+58,858
+557% +$2.92M ﹤0.01% 1221
2014
Q1
$473K Sell
10,572
-982
-8% -$44.1K ﹤0.01% 2077
2013
Q4
$544K Sell
11,554
-636
-5% -$32.2K ﹤0.01% 1773
2013
Q3
$644K Buy
12,190
+513
+4% +$24.9K ﹤0.01% 1679
2013
Q2
$527K Buy
+11,677
New +$554K ﹤0.01% 1714

Other funds holding RMD

Bank of Montreal's RMD Position: Q2 2026 in Review

Bank of Montreal increased its ResMed (RMD) stake by 14% in Q2 2026, buying an estimated $8.25M and bringing the position to 331,904 shares worth $64.7M. The position accounts for 0.02% of the portfolio, ranked #516.

Bank of Montreal first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $89.8M in Q4 2024. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bank of Montreal held 331,904 shares of ResMed worth $64.7M as of Q2 2026.
  • Bank of Montreal bought 39,815 ResMed shares in Q2 2026, an estimated $8.25M.
  • ResMed made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #516 holding.
  • Bank of Montreal first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's ResMed position peaked at $89.8M in Q4 2024.
  • 707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.